The Next Phase of Vaccine Distribution: High-Risk Medical Conditions February 16, 2021 Blog This Policy Watch examines how the 50 states and DC are defining “high-risk medical conditions” for COVID-19 vaccine prioritization, including whether they follow CDC’s recommendations or deviate in some way.
Where Do Americans Get Vaccines and How Much Does It Cost to Administer Them? February 16, 2021 Issue Brief A new issue brief shows where Americans typically get flu vaccines in the U.S. and how much it costs to administer flu and other vaccines. Among the analysis’ findings: while most people get flu vaccines at a doctor’s office or retail health clinic, White people are more likely than Black,…
States Set Different COVID-19 Vaccination Priorities for People with High-Risk Conditions February 16, 2021 News Release People with medical conditions that put them at higher risk of developing serious COVID-19 illness are next in line to get vaccinated in many states, though states are making very different choices about how to prioritize those within this large group, finds a KFF analysis of state policies. The U.S.…
This Week in Coronavirus: February 5 to February 11 February 12, 2021 Blog During the 55th week since the first coronavirus case appeared in the United States, the world is at nearly 108 million COVID-19 cases. The U.S. approached 27.4 million cases and a total of 475,400 deaths.
Reasons Vary Why People Want to “Wait and See” Before Getting a COVID-19 Vaccine. February 12, 2021 News Release Nearly a third (31%) of the public says they want to “wait and see” how a COVID-19 vaccine works for others before they would get it, representing a critical group for efforts aimed at boosting vaccinations. The latest analysis from the KFF COVID-19 Vaccine Monitor highlights how attitudes differ by…
KFF COVID-19 Vaccine Monitor: What Do We Know About Those Who Want to “Wait and See” Before Getting a COVID-19 Vaccine? February 12, 2021 Poll Finding Thirty-one percent of the public wants to “wait and see” how the COVID-19 vaccine is working for other people before getting vaccinated themselves. While they share a similar level of vaccine hesitancy, this group is not monolithic in their attitudes and beliefs. This brief examines how people with different partisan identities and those belonging to different racial and ethnic groups differ in their levels of concern about the vaccine and may respond differently to messages and information.
People of Color Especially Don’t Know Where or When to Get a COVID-19 Vaccine February 10, 2021 Slide In the January report from the COVID-19 Vaccine Monitor, the lack of information around where and when to get the COVID-19 vaccine is particularly pronounced among Hispanic and Black adults compared to White Adults. Learn more in this Chart of the Week.
Seeing Others Vaccinated May Be The Best Cure For Vaccine Hesitancy February 10, 2021 Perspective In his latest Axios column, Drew Altman shows why vaccine hesitancy will naturally decrease as more and more people see their family members and friends vaccinated without adverse consequences. It’s a hopeful sign about vaccine hesitancy, and should help free up resources to focus on the remaining vaccine hesitant.
Biden Wants to Partner with Health Centers to Promote More Equitable Access to COVID-19 Vaccines February 9, 2021 Blog We examine the Biden administration’s proposal to partner with community health centers to speed up vaccinations, especially in hard-to-reach populations.
What Will Be the Contours of the Biden Administration’s Global Health Agenda? February 9, 2021 Issue Brief This issue brief provides an overview of the Biden administration’s COVID-19 and global health actions to date, as well as likely ones on the horizon, and identifies key policy issues and outstanding questions ahead.